Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.

Acta Neuropathol 2016 06 25;131(6):833-45. Epub 2016 Jan 25.

Department of Pathology, St. Jude Children's Research Hospital, Memphis, USA.

Low-grade neuroepithelial tumors (LGNTs) are diverse CNS tumors presenting in children and young adults, often with a history of epilepsy. While the genetic profiles of common LGNTs, such as the pilocytic astrocytoma and 'adult-type' diffuse gliomas, are largely established, those of uncommon LGNTs remain to be defined. In this study, we have used massively parallel sequencing and various targeted molecular genetic approaches to study alterations in 91 LGNTs, mostly from children but including young adult patients. These tumors comprise dysembryoplastic neuroepithelial tumors (DNETs; n = 22), diffuse oligodendroglial tumors (d-OTs; n = 20), diffuse astrocytomas (DAs; n = 17), angiocentric gliomas (n = 15), and gangliogliomas (n = 17). Most LGNTs (84 %) analyzed by whole-genome sequencing (WGS) were characterized by a single driver genetic alteration. Alterations of FGFR1 occurred frequently in LGNTs composed of oligodendrocyte-like cells, being present in 82 % of DNETs and 40 % of d-OTs. In contrast, a MYB-QKI fusion characterized almost all angiocentric gliomas (87 %), and MYB fusion genes were the most common genetic alteration in DAs (41 %). A BRAF:p.V600E mutation was present in 35 % of gangliogliomas and 18 % of DAs. Pathogenic alterations in FGFR1/2/3, BRAF, or MYB/MYBL1 occurred in 78 % of the series. Adult-type d-OTs with an IDH1/2 mutation occurred in four adolescents, the youngest aged 15 years at biopsy. Despite a detailed analysis, novel genetic alterations were limited to two fusion genes, EWSR1-PATZ1 and SLMAP-NTRK2, both in gangliogliomas. Alterations in BRAF, FGFR1, or MYB account for most pathogenic alterations in LGNTs, including pilocytic astrocytomas, and alignment of these genetic alterations and cytologic features across LGNTs has diagnostic implications. Additionally, therapeutic options based upon targeting the effects of these alterations are already in clinical trials.

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2Fs00401-016-15
Web Search
http://link.springer.com/10.1007/s00401-016-1539-z
Publisher Site
http://dx.doi.org/10.1007/s00401-016-1539-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866893PMC
June 2016
196 Reads

Publication Analysis

Top Keywords

genetic alterations
12
neuroepithelial tumors
12
fgfr1 myb
8
braf fgfr1
8
genetic alteration
8
alterations
8
pathogenic alterations
8
fusion genes
8
angiocentric gliomas
8
alterations lgnts
8
lgnts
8
low-grade neuroepithelial
8
genetic
7
tumors
6
contrast myb-qki
4
myb-qki fusion
4
fusion characterized
4
characterized angiocentric
4
d-ots contrast
4
dnets 40 %
4

References

(Supplied by CrossRef)

MJ Alvarez-Cubero et al.
Urol Oncol 2013

JL Anderson et al.
Handb Clin Neurol 2015

F Andre et al.
Clin Cancer Res 2013

P Bandopadhayay et al.
Pediatr Blood Cancer 2014

AP Becker et al.
J Neuropathol Exp Neurol 2015

G Bird-Lieberman et al.
J Neurosurg Pediatr 2011

I Blumcke et al.
Acta Neuropathol 2014

DJ Brat et al.
N Engl J Med 2015

CW Brennan et al.
Cell 2013

C Chappé et al.
Brain Pathol 2013

E Clappier et al.
Blood 2007

Similar Publications